A vs ZYME
Agilent Technologies Inc (A) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
A currently screens at market cap $33.70B and trailing P/E 29.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the A and ZYME stock pages for the full models.
Not investment advice.